lncRNA SNHG3在肿瘤中的研究进展

姚怿聪; 吴登龙

doi:10.13201/j.issn.1001-1420.2021.03.017

lncRNA SNHG3在肿瘤中的研究进展

姚怿聪¹,
吴登龙^2, ,

- 1. 同济大学(上海, 200092);
- 2. 同济大学附属同济医院泌尿外科
基金项目:
国家自然科学基金(No:81672526,81802560)

上海市卫健委临床研究专项计划(No:20184Y0263,20184Y0105)

详细信息

通讯作者: 吴登龙,E-mail:wudenglong@163.com

中图分类号: R73

收稿日期: 2020-01-04

Research progress of lncRNA SNHG3 in tumors

YAO Yicong¹,
WU Denglong^2, ,

- 1. Tongji University, Shanghai, 200092, China;
- 2. Department of Urology, Tongji Hospital Affiliated to Tongji University

More Information

Corresponding author: WU Denglong, E-mail: wudenglong@163.com

Received Date: 04 January 2020

摘要

摘要: 长链非编码RNA(long non-coding RNA,lncRNA)是一类转录本长度＞200 nt的不编码蛋白质的RNA分子。近年来研究发现长链非编码RNA在诸多肿瘤的发生发展过程中发挥重要作用。lncRNA SNHG3是一种近年被广泛探究的典型lncRNA。研究不断深入,lncRNASNHG3被发现可能与人体各系统中肿瘤的发生发展有关,如消化系统、呼吸系统、神经系统、生殖系统、泌尿系统等,且机制各异,可能为多种肿瘤的治疗提供新的潜在治疗靶点,有着广泛的研究前景。本文结合国内外最新报道,就lncRNA SNHG3影响多种肿瘤发生发展的最新研究进展进行简要综述。
- SNHG3 /
- lncRNA /
- 肿瘤 /
- 研究进展
Abstract: Long non-coding RNA(lncRNA) is a class of RNA molecules that do not encode proteins with transcripts longer than 200 nt. Recent studies have found that lncRNAs play an important role in the occurrence and development of many tumors. lncRNA SNHG3 is a typical lncRNA that has been widely explored in recent years. With the deepening of research, lncRNA SNHG3 has been found to be related to the occurrence and development of tumors in various human systems, such as the digestive system, respiratory system, nervous system, reproductive system and urinary system. Treatment offers new potential therapeutic targets and has extensive research prospects. Based on the latest reports at home and abroad, this article briefly reviews the latest research progress on the influence of SNHG3 on the development of multiple tumors.
- SNHG3 /
- lncRNA /
- tumor /
- research progress

HTML全文

参考文献(68)

[1]	Zugazagoitia J,Guedes C,Ponce S,et al.Current Challenges in Cancer Treatment[J].Clin Ther,2016,38(7):1551-1566.
[2]	Siegel RL,Miller KD,Fedewa SA,et al.Colorectal cancer statistics,2017[J].CA Cancer J Clin,2017,67(3):177-193.
[3]	Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[4]	Chen R,Bouck JB,Weinstock GM,et al.Comparing vertebrate whole-genome shotgun reads to the human genome[J].Genome Res,2001,11(11):1807-1816.
[5]	Wang L,Ma L,Xu F,et al.Role of long non-coding RNA in drug resistance in non-small cell lung cancer[J].Thorac Cancer,2018,9(7):761-768.
[6]	Tang Q,Hann SS.HOTAIR:An Oncogenic Long Non-Coding RNA in Human Cancer[J].Cell Physiol Biochem,2018,47(3):893-913.
[7]	Zhang PF,Wang F,Wu J,et al.LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma[J].J Cell Physiol,2019,234(3):2788-2794.
[8]	Huang W,Tian Y,Dong S,et al.The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer[J].Oncol Rep,2017,38(3):1402-1410.
[9]	Zheng S,Jiang F,Ge D,et al.LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma[J].Biomed Pharmacother,2019,112:108695.
[10]	Liu L,Ni J,He X.Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation[J].Dis Markers,2018,2018:5736716.
[11]	Liu J,Zhu J,Xu H,et al.Effects of the HN Antigenic Difference between the Vaccine Strain and the Challenge Strain of Newcastle Disease Virus on Virus Shedding and Transmission[J].Viruses,2017,9(8):225.
[12]	Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma[J].Lancet,2012,379(9822):1245-1255.
[13]	Wen X,Yao M,Lu Y,et al.Integration of Prealbumin into Child-Pugh Classification Improves Prognosis Predicting Accuracy in HCC Patients Considering Curative Surgery[J].J Clin Transl Hepatol,2018,6(4):377-384.
[14]	Maluccio M,Covey A.Recent progress in understanding,diagnosing,and treating hepatocellular carcinoma[J].CA Cancer J Clin,2012,62(6):394-399.
[15]	Deng L,Yang SB,Xu FF,et al.Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge[J].J Exp Clin Cancer Res,2015,34:18.
[16]	Sui CJ,Zhou YM,Shen WF,et al.Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429[J].J Mol Med(Berl),2016,94(11):1281-1296.
[17]	Li J,Zhang Z,Xiong L,et al.SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer[J].Biochem Biophys Res Commun,2017,487(1):146-152.
[18]	Zhao L,Han T,Li Y,et al.The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4[J].FASEB J,2017,31(3):893-903.
[19]	Kim Y,Kim H,Park H,et al.miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs[J].J Biol Chem,2014,289(40):28019-28039.
[20]	Li Y,Gao Y,Xu Y,et al.Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer[J].Growth Factors,2015,33(4):267-274.
[21]	Cao L,Wang J,Wang PQ.MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma[J].Biomed Pharmacother,2016,84:828-835.
[22]	Wu X,Cao X,Chen F.WITHDRAWN:LncRNA-HOTAIR Activates Tumor Cell Proliferation and Migration by Suppressing MiR-326 in Cervical Cancer[J].Oncol Res,2017.
[23]	Zhang P,Kong F,Deng X,et al.MicroRNA-326 suppresses the proliferation,migration and invasion of cervical cancer cells by targeting ELK1[J].Oncol Lett,2017,13(5):2949-2956.
[24]	Yin S,Du W,Wang F,et al.MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway[J].Cancer Biol Ther,2018,19(4):260-270.
[25]	Yang YA,Zhang GM,Feigenbaum L,et al.Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2[J].Cancer Cell,2006,9(6):445-457.
[26]	Zhang T,Cao C,Wu D,et al.SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma[J].Tumour Biol,2016,37(2):2379-2385.
[27]	Bai WD,Ye XM,Zhang MY,et al.MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer[J].Int J Cancer,2014,135(6):1356-1368.
[28]	Lee JY,Park MK,Park JH,et al.Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer[J].Oncogene,2014,33(10):1325-1335.
[29]	Cao Y,Liu Y,Ping F,et al.miR-200b/c attenuates lipopolysaccharide-induced early pulmonary fibrosis by targeting ZEB1/2 via p38 MAPK and TGF-β/smad3 signaling pathways[J].Lab Invest,2018,98(3):339-359.
[30]	Tay Y,Rinn J,Pandolfi PP.The multilayered complexity of ceRNA crosstalk and competition[J].Nature,2014,505(7483):344-352.
[31]	Sipos F,Firneisz G,Müzes G.Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases[J].World J Gastroenterol,2016,22(35):7938-7950.
[32]	Feng XH,Liang YY,Liang M,et al.Direct Interaction of c-Myc with Smad2 and Smad3 to Inhibit TGF-β-Mediated Induction of the CDK Inhibitor p15(Ink4B)[J].Mol Cell,2016,63(6):1089.
[33]	Pazos E,Garcia-Algar M,Penas C,et al.Surface-Enhanced Raman Scattering Surface Selection Rules for the Proteomic Liquid Biopsy in Real Samples:Efficient Detection of the Oncoprotein c-MYC[J].J Am Chem Soc,2016,138(43):14206-14209.
[34]	Xuan Y,Wang Y.Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation[J].Cell Death Dis,2019,10(10):694.
[35]	Lu L,Yu XY,Zhang LL,et al.The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression[J].Int J Mol Sci,2017,18(1):226.
[36]	Zhao L,Sun H,Kong H,et al.The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation,Migration and EMT Phenotype Formation Through Sponging Mir-382[J].Cell Physiol Biochem,2017,42(6):2145-2158.
[37]	Hu JJ,Song W,Zhang SD,et al.HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling[J].Sci Rep,2016,6:23521.
[38]	Han T,Jiao F,Hu H,et al.EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin,partly through association with MALAT-1 in pancreatic cancer[J].Oncotarget,2016,7(10):11194-11207.
[39]	Li R,Sun R,Hicks GR,et al.Arabidopsis ribosomal proteins control vacuole trafficking and developmental programs through the regulation of lipid metabolism[J].Proc Natl Acad Sci U S A,2015,112(1):E89-E98.
[40]	Karreth FA,Pandolfi PP.ceRNA cross-talk in cancer:when ce-bling rivalries go awry[J].Cancer Discov,2013,3(10):1113-1121.
[41]	Liu XH,Sun M,Nie FQ,et al.Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer[J].Mol Cancer,2014,13:92.
[42]	Kauppi M,Simonsen A,Bremnes B,et al.The small GTPase Rab22 interacts with EEA1 and controls endosomal membrane trafficking[J].J Cell Sci,2002,115(Pt 5):899-911.
[43]	He H,Dai F,Yu L,et al.Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues[J].Gene Expr,2002,10(5-6):231-242.
[44]	Ogier-Denis E,Bauvy C,Cluzeaud F,et al.Glucose persistence on high-mannose oligosaccharides selectively inhibits the macroautophagic sequestration of N-linked glycoproteins[J].Biochem J,2000,345 Pt 3:459-466.
[45]	Huang C,Liu S,Wang H,et al.LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer[J].Am J Transl Res,2016,8(11):5025-5034.
[46]	Meng Q,Ren MM,Li YG,et al.LncRNA-RMRP Acts as an Oncogene in Lung Cancer[J].PloS one,2016,11(12):e0164845.
[47]	Zhou C,Ye L,Jiang C,et al.Long noncoding RNA HOTAIR,a hypoxia-inducible factor-1α activated driver of malignancy,enhances hypoxic cancer cell proliferation,migration,and invasion in non-small cell lung cancer[J].Tumour Biol,2015,36(12):9179-9188.
[48]	Lin PC,Huang HD,Chang CC,et al.Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2[J].BMC Cancer,2016,16:583.
[49]	Jia X,Wang ZC,Qiu L,et al.Upregulation of LncRNA-HIT promotes migration and invasion of non-small cell lung cancer cells by association with ZEB1[J].Cancer Med,2016,5(12):3555-3563.
[50]	Fei F,He Y,He S,et al.LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21[J].Biosci Rep,2018,38(5):BSR20180420.
[51]	Black AR,Black JD,Azizkhan-Clifford J.Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer[J].J Cell Physiol,2001,188(2):143-160.
[52]	Kaczynski J,Cook T,Urrutia R.Sp1-and Krüppel-like transcription factors[J].Genome Biol,2003,4(2):206.
[53]	Shen P,Sun JB,Xu GQ,et al.KLF9,a transcription factor induced in flutamide-caused cell apoptosis,inhibits AKT activation and suppresses tumor growth of prostate cancer cells[J].Prostate,2014,74(9):946-958.
[54]	Hsu LS,Chan CP,Chen CJ,et al.Decreased Kruppel-like factor 4(KLF4) expression may correlate with poor survival in gastric adenocarcinoma[J].Med Oncol,2013,30(4):632.
[55]	Wu J,Lingrel JB.KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1[J].Oncogene,2004,23(49):8088-8096.
[56]	Taniguchi H,Jacinto FV,Villanueva A,et al.Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer[J].Oncogene,2012,31(15):1988-1994.
[57]	Cheetham SW,Gruhl F,Mattick JS,et al.Long noncoding RNAs and the genetics of cancer[J].Br J Cancer,2013,108(12):2419-2425.
[58]	Hong L,Chen WS,Wu D,et al.Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer[J].Cancer Biomark,2018,22(3):367-374.
[59]	Lu J,Xu Y,Wei X,et al.Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway[J].Biomed Res Int,2016,2016:6253280.
[60]	Sun J,Yang X,Zhang R,et al.GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer[J].Cancer Med,2017,6(4):834-844.
[61]	Li J,Yang S,Su N,et al.Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer[J].Tumour Biol,2016,37(2):2057-2065.
[62]	Zhang C,Qu Y,Xiao HB,et al.LncRNA SNHG3 promotes clear cell renal cell carcinoma proliferation and migration by upregulating TOP2A[J].Exp Cell Res,2019,384(1):111595.
[63]	Qu Y,Xiao HB,Xiao W,et al.Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma[J].Cell Physiol Biochem,2018,48(3):1075-1087.
[64]	Salmena L,Poliseno L,Tay Y,et al.A ceRNA hypothesis:the Rosetta Stone of a hidden RNA language?[J].Cell,2011,146(3):353-358.
[65]	Delgado JL,Hsieh CM,Chan NL,et al.Topoisomerases as anticancer targets[J].Biochem J,2018,475(2):373-398.
[66]	Zhou Q,Abraham AD,Li L,et al.Topoisomerase Ⅱα mediates TCF-dependent epithelial-mesenchymal transition in colon cancer[J].Oncogene,2016,35(38):4990-4999.
[67]	Parker AS,Eckel-Passow JE,Serie D,et al.Higher expression of topoisomerase Ⅱ alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma[J].Eur Urol,2014,66(5):929-935.
[68]	Pei YF,Yin XM,Liu XQ.TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway[J].Biochim Biophys Acta Mol Basis Dis,2018,1864(1):197-207.